Evidence map›Paper›PMID 42045679›Full record

ArticleEMBO molecular medicine2026

Disease-stage-specific immunometabolic remodeling in pediatric obstructive sleep apnea: a single-cell transcriptomic atlas of adenoid tissue.

Qin Yang, Yunfei Cui, Xiao Huang, Junlin Liu, Xiaopeng Ma, George Fu Gao, Hongguang Pan, Shijie Qin

Abstract read
In one paragraph

Article in EMBO molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qin YangDepartment of Sleep Medicine Center, Shenzhen Children's Hospital, Shenzhen, 518038, China.
Yunfei CuiDepartment of Sleep Medicine Center, Shenzhen Children's Hospital, Shenzhen, 518038, China.ORCID 0009-0009-5054-4368
Xiao HuangDepartment of Sleep Medicine Center, Shenzhen Children's Hospital, Shenzhen, 518038, China.
Junlin LiuFaculty of Health Sciences, University of Macau, Macau SAR, China.
Xiaopeng MaDepartment of Sleep Medicine Center, Shenzhen Children's Hospital, Shenzhen, 518038, China.
George Fu GaoCAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, 100101, China.ORCID 0000-0002-3869-615X
Hongguang PanDepartment of Otolaryngology, Shenzhen Children's Hospital, Shenzhen, 518038, China. 23xylai1@stu.edu.cn.
Shijie QinInnovative Vaccine and Immunotherapy Research Center, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, 310009, China. qinshijie1994@zju.edu.cn.ORCID 0009-0000-3592-1131

Funding

Guangdong Basic and Applied Basic Research Foundation 2023A1515110489Guangdong High-level Hospital Construction Fund Clinical Research Project of Shenzhen Children's Hospital LCYJ2022097MOST | National Natural Science Foundation of China (NSFC) 82300030MOST | National Natural Science Foundation of China (NSFC) 82500007
6 · The paper itself

Abstract

Hypertrophied adenoids in children can impair breathing and lead to obstructive sleep apnea (OSA), often accompanied by abnormal growth and weakened stamina and immunity. However, the cause of the pathological transformation in these originally immune-enhancing lymphoid tissues remains unclear. Our study provides the first single cell transcriptomic and immune repertoire atlas of adenoids from normal snoring to mild, moderate, and severe OSA, and identified markedly asynchronous functional modules, transcriptional regulatory networks and intercellular communications during the progression of OSA. Children with severe OSA exhibited exhibit active Hippo, Notch, and Wnt signaling, alongside significant downregulation of energy synthesis. Analysis revealed compromised T-cell and B-cell immunity, as well as reduced antigen processing by innate immune cells, coupled with diminished cell-cell communication in severe OSA group. T-cell receptor and B-cell receptor sequencing results also support more infection imprints and abnormal germinal centers and antibody class switching. Mechanistically, HIF1A-mediated hypoxic signaling likely drives the downregulation of key immune components (including HLA and interferon molecules), positioning it as a promising therapeutic target for OSA.

Indexed as

AdenoidsSleep Apnea, ObstructiveTranscriptomeB-LymphocytesChildChild, PreschoolFemaleHumansMaleSignal TransductionSingle-Cell Gene Expression AnalysisT-Lymphocytes

Identifiers

PMID42045679
PMCPMC13270133

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.